Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) currently has a daily average trading volume of 3.79M but it saw 6271244 shares traded in last market. With a market cap of 121.36M USD, the company’s current market price of $0.75 came rising about 3.85 while comparing to the previous closing price of $0.72. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.45 and as low as $0.59. In the recent trading on the day, stock has struck highest price mark of $0.6507 while lowest mark touched by it was $0.8242.
Taking a look at 20-day trading activity of Ironwood Pharmaceuticals Inc (IRWD) gives us an average price of $1.2383, while its current price level is -91.12% below from 52-week high level whereas it is 26.90% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.5139 while that of 200 days or SMA-200 reads an average of $3.7983. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.36% during that period while stretching the period over a month that decreases to 11.89%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 23.07 which implies that the stock is in oversold territory.
Over the week, IRWD’s stock price is moving -27.18% down while it is -48.28% when we observe its performance for the past one month. Year-to-date it is -83.07% down and over the past year, the stock is showing a downside performance of -90.37%.
The company is expected to be releasing its next quarterly report on 2025-Feb-26, for which analysts forecasted an EPS of -0.01 while estimate for next year EPS is 0.16. In next quarter, company is expected to be making quarterly sales of $72.03M as analysts are expecting the sales for current fiscal year at $287.07M and seeing the company making $308.36M in sales next year. Moreover, analysts are in estimates of $66.77M for current-quarter revenue.
Currently, Ironwood Pharmaceuticals Inc’s total number of outstanding shares is 160.21M with 1.94% of that held by the insiders while 102.21% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 0.61% and return on equity (ROE) at -559.14%. It has a price to earnings ratio (P/E ratio) of 69.44 while having a 2.21 of forward P/E ratio. Stock’s beta reads 0.50. Stock has a price to sale or P/S ratio amounts to 0.35. Its return on asset (ROA) is 0.44% on average.
